In 2007, the Danish Medicines Agency achieved a target performance of 93.3 per cent in respect of the targets set out in the performance contract with the Danish Ministry of Health and Prevention, corresponding to a fulfilment of three in every four sub-requirements. Overall, we assess that we delivered good technical results in 2007, among other things, based on the fact that the most strategically important performance requirements were fulfilled.
In 2007, we reached a surplus for the year of DKK 20.3 million, which is considerably better than the deficit of DKK 2.9 million forecast in the Danish Finance Act 2007 (the Budget). The surplus may primarily be ascribed to significantly higher activity, i.e. inflow of cases, compared with our expectations and activities in previous years. We find the overall results for 2007 satisfactory. We intend to use the surplus for the year on development projects.
The full report, which is in Danish only, is available in the box.
Danish Medicines Agency, 22 April 2008